Latest Insider Transactions at Bio Xcel Therapeutics, Inc. (BTAI)
This section provides a real-time view of insider transactions for Bio Xcel Therapeutics, Inc. (BTAI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BioXcel Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BioXcel Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 03
2024
|
Frank Yocca Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,175
-20.24%
|
$0
$0.55 P/Share
|
|
Oct 03
2024
|
Javier Rodriguez Officer |
SELL
Open market or private sale
|
Direct |
6,863
-22.4%
|
$0
$0.55 P/Share
|
|
Oct 03
2024
|
Matthew T. Wiley Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,272
-24.81%
|
$0
$0.55 P/Share
|
|
Oct 03
2024
|
Vincent O'Neill Officer |
SELL
Open market or private sale
|
Direct |
5,556
-22.09%
|
$0
$0.55 P/Share
|
|
Oct 03
2024
|
Richard I Steinhart Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,175
-26.13%
|
$0
$0.55 P/Share
|
|
Sep 17
2024
|
Frank Yocca Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,250
+37.48%
|
-
|
|
Sep 17
2024
|
Javier Rodriguez Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,250
+40.96%
|
-
|
|
Sep 17
2024
|
Matthew T. Wiley Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,250
+45.67%
|
-
|
|
Sep 17
2024
|
Vincent O'Neill Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,250
+45.79%
|
-
|
|
Sep 17
2024
|
Richard I Steinhart Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,250
+43.63%
|
-
|
|
Sep 16
2024
|
Javier Rodriguez Officer |
SELL
Open market or private sale
|
Direct |
345
-3.64%
|
$0
$0.69 P/Share
|
|
Sep 16
2024
|
Richard I Steinhart Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
356
-5.43%
|
$0
$0.69 P/Share
|
|
Sep 16
2024
|
Vimal Mehta CEO and President |
SELL
Open market or private sale
|
Direct |
1,982
-1.86%
|
$0
$0.69 P/Share
|
|
Sep 16
2024
|
Frank Yocca Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
355
-2.44%
|
$0
$0.69 P/Share
|
|
Sep 16
2024
|
Matthew T. Wiley Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
215
-5.06%
|
$0
$0.69 P/Share
|
|
Sep 16
2024
|
Vincent O'Neill Officer |
SELL
Open market or private sale
|
Direct |
138
-3.41%
|
$0
$0.69 P/Share
|
|
Sep 15
2024
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
563
+5.61%
|
-
|
|
Sep 15
2024
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
563
+7.9%
|
-
|
|
Sep 15
2024
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+6.12%
|
-
|
|
Sep 15
2024
|
Frank Yocca Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
563
+3.72%
|
-
|
|
Sep 15
2024
|
Matthew T. Wiley Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+15.01%
|
-
|
|
Sep 14
2024
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+5.52%
|
-
|
|
Sep 14
2024
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+7.99%
|
-
|
|
Sep 14
2024
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,609
+4.95%
|
-
|
|
Sep 14
2024
|
Frank Yocca Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+3.59%
|
-
|
|
Sep 14
2024
|
Vincent O'Neill Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+11.41%
|
-
|
|
Jun 17
2024
|
Vimal Mehta CEO and President |
SELL
Open market or private sale
|
Direct |
2,134
-4.3%
|
$2,134
$1.28 P/Share
|
|
Jun 17
2024
|
Vincent O'Neill Officer |
SELL
Open market or private sale
|
Direct |
155
-4.21%
|
$155
$1.28 P/Share
|
|
Jun 17
2024
|
Javier Rodriguez Officer |
SELL
Open market or private sale
|
Direct |
361
-4.12%
|
$361
$1.26 P/Share
|
|
Jun 17
2024
|
Richard I Steinhart Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
372
-6.36%
|
$372
$1.26 P/Share
|
|
Jun 17
2024
|
Matthew T. Wiley Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
244
-6.52%
|
$244
$1.26 P/Share
|
|
Jun 17
2024
|
Frank Yocca Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
372
-2.69%
|
$372
$1.28 P/Share
|
|
Jun 15
2024
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+6.58%
|
-
|
|
Jun 15
2024
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
562
+6.03%
|
-
|
|
Jun 15
2024
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
562
+8.77%
|
-
|
|
Jun 15
2024
|
Matthew T. Wiley Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+16.7%
|
-
|
|
Jun 15
2024
|
Frank Yocca Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
562
+3.9%
|
-
|
|
Jun 14
2024
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,609
+5.35%
|
-
|
|
Jun 14
2024
|
Vincent O'Neill Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+12.4%
|
-
|
|
Jun 14
2024
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+5.98%
|
-
|
|
Jun 14
2024
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+8.97%
|
-
|
|
Jun 14
2024
|
Frank Yocca Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+3.77%
|
-
|
|
Jun 05
2024
|
Vimal Mehta CEO and President |
SELL
Open market or private sale
|
Indirect |
409,136
-50.81%
|
$409,136
$1.58 P/Share
|
|
Jun 04
2024
|
Vimal Mehta CEO and President |
SELL
Open market or private sale
|
Indirect |
1,018,358
-19.57%
|
$1,018,358
$1.63 P/Share
|
|
Apr 04
2024
|
Frank Yocca Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,067
-7.72%
|
$2,134
$2.63 P/Share
|
|
Apr 04
2024
|
Javier Rodriguez Officer |
SELL
Open market or private sale
|
Direct |
1,012
-11.65%
|
$2,024
$2.64 P/Share
|
|
Apr 04
2024
|
Matthew T. Wiley Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,008
-25.2%
|
$2,016
$2.64 P/Share
|
|
Apr 04
2024
|
Richard I Steinhart Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,069
-18.32%
|
$2,138
$2.63 P/Share
|
|
Apr 04
2024
|
Vimal Mehta CEO and President |
SELL
Open market or private sale
|
Direct |
5,268
-5.47%
|
$10,536
$2.62 P/Share
|
|
Apr 04
2024
|
Vincent O'Neill Officer |
SELL
Open market or private sale
|
Direct |
165
-2.96%
|
$330
$2.62 P/Share
|